Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Peyton Blake
Diabetic neuropathy-induced allodynia is a distressing sensory abnormality characterized by the perception of pain in response to non-painful stimuli. This phenomenon significantly impairs the quality of life for individuals with diabetes. Primary afferent nerves, responsible for pain signal transmission, undergo structural and functional changes in diabetic neuropathy. Chronic hyperglycemia leads to nerve damage and sensitization of primary afferent nerves, contributing to aberrant pain processing. Mechanisms underlying allodynia include axonal degeneration, demyelination, metabolic disturbances, inflammation, and altered expression of ion channels and receptors. Upregulated sodium channels, such as Nav1.7 and Nav1.8, enhance nerve excitability, while changes in TRP channels (TRPV1, TRPA1) increase sensitivity to thermal and chemical stimuli. Altered opioid receptors, neurotransmitters (substance P, CGRP), and neurotrophic factors further modulate pain perception. Understanding primary afferent nerve function in diabetic neuropathy-induced allodynia may aid in developing targeted therapies, including channel blockers, TRP channel antagonists, and anti-inflammatory agents, to alleviate this debilitating symptom.